Nerurkar
Esha Nerurkar, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20150310310 | ELECTRONIC DEVICE LOCALIZATION BASED ON IMAGERY - An electronic device includes one or more imaging cameras. After a reset of the device or other specified event, the electronic device identifies an estimate of the device's pose based on location data such as Global Positioning System (GPS) data, cellular tower triangulation data, wireless network address location data, and the like. The one or more imaging cameras may be used to capture imagery of the local environment of the electronic device, and this imagery is used to refine the estimated pose to identify a refined pose of the electronic device. The refined pose may be used to identify additional imagery information, such as environmental features, that can be used to enhance the location based functionality of the electronic device. | 10-29-2015 |
Esha D. Nerurkar, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20140333741 | CONSTRAINED KEY FRAME LOCALIZATION AND MAPPING FOR VISION-AIDED INERTIAL NAVIGATION - Estimation techniques for vision-aided inertial navigation are described. In one example, a vision-aided inertial navigation system (VINS) comprises an image source to produce image data for a keyframe and one or more non-keyframes along a trajectory, the one or more non-keyframes preceding the keyframe along the trajectory. The VINS comprises an inertial measurement unit (IMU) to produce IMU data indicative of a motion of the VINS along the trajectory for the keyframe and the one or more non-keyframes, and a processing unit comprising an estimator that processes the IMU data and the image data to compute state estimates of the VINS. The estimator computes the state estimates of the VINS for the keyframe by constraining the state estimates based on the IMU data and the image data for the one or more non-keyframes of the VINS without computing state estimates of the VINS for the one or more non-keyframes. | 11-13-2014 |
Kedar K. Nerurkar, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20090048335 | PROCESS FOR PREPARING SIMVASTATIN - Preparation of simvastatin. | 02-19-2009 |
Laxmikant N. Nerurkar, Edmond, OK US
Maneesh Nerurkar, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20110287091 | CHRONOTHERAPEUTIC PHARMACEUTICAL COMPOSITION - The present invention relates to chronotherapeutic pharmaceutical compositions and a method of preparing the same. The composition comprises of at least one active ingredient, a pH independent agent and a hydrophilic agent. The active ingredient in the composition is coated with the pH independent agent. The composition provides a dual controlled release system, which aids in an initial lag time of 4-6 hours and controlled release of the active ingredient up to 24 hours. | 11-24-2011 |
Maneesh Nerurkar, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20130171199 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION - An oral controlled release pharmaceutical composition comprising a core and a polymer dispersion and its preparation method are disclosed. The core is selected from the group consisting of ‘the drug coated core’ and ‘the drug loaded core’. The drug coated core comprises an inert excipient based sphere and a coat of drug composition. The drug loaded core comprises at least a drug, a binder and at least one pharmaceutically acceptable excipient. The polymer dispersion used to coat the core comprises at least one controlled release polymer and at least one pharmaceutically acceptable excipient. The oral controlled release pharmaceutical composition further comprises an in-situ gelling system comprising at least one gelling polymer. | 07-04-2013 |
Manoj Nerurkar, Pune IN
Patent application number | Description | Published |
---|---|---|
20090186903 | ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD - An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided. | 07-23-2009 |
Manoj Nerurkar, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20100166774 | Stable Protein Formulations - The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction. | 07-01-2010 |
Manoj Nerurkar, Kaiyani Nagar IN
Patent application number | Description | Published |
---|---|---|
20130216541 | STABLE SUBCUTANEOUS PROTEIN FORMULATIONS AND USES THEREOF - The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction. | 08-22-2013 |
Manoj Nerurkar, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20130045981 | ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD - An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided. | 02-21-2013 |
20140235574 | ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD - An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided. | 08-21-2014 |
20150024056 | CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD - A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle thereof, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided. | 01-22-2015 |
20150328335 | ARIPIPRAZOLE COMPLEX FORUMLATION AND METHOD - An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided. | 11-19-2015 |
Manoj Nerurkar, Monmouth Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20110160224 | ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD - An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided. | 06-30-2011 |
20120100190 | CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD - A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided. | 04-26-2012 |
20140018369 | CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD - A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided. | 01-16-2014 |
Nandan Nerurkar, Philadelhia, PA US
Patent application number | Description | Published |
---|---|---|
20110098826 | Disc-Like Angle-Ply Structures for Intervertebral Disc Tissue Engineering and Replacement - Provided are implant scaffolds comprising angle-ply arrays of two or more layers of substantially aligned fiber, methods of making and using said scaffolds, and kits comprising such scaffolds. | 04-28-2011 |
Sachin M. Nerurkar, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20160110435 | COPYING DATASETS BETWEEN DATA INTEGRATION SYSTEMS - According to one embodiment, a method of copying a dataset associated with a first extract, transform, and load (ETL) job in a first data integration system to a second data integration system comprises copying executable code associated with the first ETL job from the first to the second system. Operating system software, integration system software, and file system structure are substantially identical between the first and second systems. The method further comprises executing the second ETL job to read the dataset from the first data integration system and write the dataset to the second data integration system. The second ETL job is associated with configuration parameters specifying storage resources in the first system associated with the dataset and destination parameters specifying storage resources in the second system. The method further comprises copying metadata generated by the second ETL job from the first to the second data integration system. | 04-21-2016 |